Cardiology - Reviews
10 July 2025
Early Access
ST-elevation myocardial infarction late-presenting patients: time for a new paradigm?
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
9
Views
2
Downloads
Authors
Timely performed percutaneous coronary angioplasty (PCI) remains the most critical factor predicting favorable outcomes in patients with ST-elevation myocardial infarction (STEMI). Guidelines have traditionally identified the first 12 hours from symptom onset as the "golden window" for PCI. However, recommendations for patients presenting beyond this timeframe remain inconsistent. Late presenters are associated with worse outcomes and significantly higher rates of in-hospital mortality. Notably, the recent COVID-19 pandemic has further increased the prevalence of late presentations. Emerging imaging techniques now offer new opportunities to better characterize both patients and the pathological consequences of late-presented STEMI. Despite this progress, evidence supporting the adoption of imaging-guided strategies remains mixed. These advancements hold the potential to pave the way for personalized management approaches for this heterogeneous patient population soon. In this review, we explore the current evidence regarding the treatment of late presenters and discuss how emerging imaging techniques may transform clinical strategies in this challenging subset of STEMI patients.
Altmetrics
Downloads
Download data is not yet available.
Citations
Danchin N, Popovic B, Puymirat E, et al. Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme. Eur Heart J 2020;41:858-66. DOI: https://doi.org/10.1093/eurheartj/ehz665
Terkelsen CJ, Sørensen JT, Maeng M, et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA 2010;304:763-71. DOI: https://doi.org/10.1001/jama.2010.1139
Wong CK, Bucciarelli-Ducci C. Q waves and failed ST resolution: will intra-myocardial haemorrhage be a concern in reperfusing "late presenting" STEMIs? Int J Cardiol 2015;182:203-10. DOI: https://doi.org/10.1016/j.ijcard.2014.12.057
Late assessment of thrombolytic efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993;342:759-66. DOI: https://doi.org/10.1016/0140-6736(93)91538-W
Rovelli F, De Vita C, Feruglio GA, et al. GISSI trial: early results and late follow-up. J Am Coll Cardiol 1987;10:33B-9. DOI: https://doi.org/10.1016/S0735-1097(87)80426-6
Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023;44:3720-6. DOI: https://doi.org/10.1093/eurheartj/ehad191
Rao SV, Mehran R, Jneid H, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation 2025:151:e771-862.
Jäger B, Farhan S, Rohla M, et al. Clinical predictors of patient-related delay in the VIENNA ST-elevation myocardial infarction network and impact on long-term mortality. Eur Heart J Acute Cardiovasc Care 2017;6:254-61. DOI: https://doi.org/10.1177/2048872616633882
Fu R, Li SD, Song CX, et al. Clinical significance of diabetes on symptom and patient delay among patients with acute myocardial infarction—an analysis from China Acute Myocardial Infarction (CAMI) registry. J Geriatr Cardiol 2019;16:395-400.
Cho KH, Han X, Ahn JH, et al. Long-term outcomes of patients with late presentation of ST-segment elevation myocardial infarction. J Am Coll Cardiol 2021;77:1859-70.
Bouisset F, Gerbaud E, Bataille V, et al. Percutaneous myocardial revascularization in late-presenting patients with STEMI. J Am Coll Cardiol 2021;78:1291-305. DOI: https://doi.org/10.1016/j.jacc.2021.07.039
Meyer MR, Arnold M, Rössler K, et al. Gender differences in patient and system delay for primary percutaneous coronary intervention: current trends in a Swiss ST-segment elevation myocardial infarction population. Eur Heart J Acute Cardiovasc Care 2019;8:283-90. DOI: https://doi.org/10.1177/2048872618810410
Schulte KJ, Mayrovitz HN. Myocardial infarction signs and symptoms: females vs. males. Cureus 2023;15:e37522. DOI: https://doi.org/10.7759/cureus.37522
Lim SC, Rahman A, Yaacob NM. Pre-hospital factors influencing time of arrival at emergency departments for patients with acute ST-elevation myocardial infarction. Malays J Med Sci 2019;26:87-98. DOI: https://doi.org/10.21315/mjms2019.26.1.8
Weininger D, Cordova JP, Wilson E, et al. Delays to hospital presentation in women and men with ST-segment elevation myocardial infarction: a multi-center analysis of patients hospitalized in New York City. Ther Clin Risk Manag 2022;18:1-9. DOI: https://doi.org/10.2147/TCRM.S335219
Cerrato E, Forno D, Ferro S, Chinaglia A. Characteristics, in-hospital management and outcome of late acute ST-elevation myocardial infarction presenters. J Cardiovasc Med 2017;18:567-71. DOI: https://doi.org/10.2459/JCM.0000000000000527
Obling L, Frydland M, Hansen R, et al. Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients. Eur Heart J Acute Cardiovasc Care 2018;7:7-15. DOI: https://doi.org/10.1177/2048872617706503
Roberto M, Radovanovic D, de Benedetti E, et al. Temporal trends in latecomer STEMI patients: insights from the AMIS Plus registry 1997-2017. Rev Esp Cardiol 2020;73:741-8. DOI: https://doi.org/10.1016/j.rec.2019.10.001
Toscano O, Cosentino N, Campodonico J, et al. Acute myocardial infarction during the COVID-19 pandemic: an update on clinical characteristics and outcomes. Front Cardiovasc Med 2021;8:648290. DOI: https://doi.org/10.3389/fcvm.2021.648290
Hodas R, Benedek I, Rat N, et al. Impact of COVID-19 pandemic on STEMI networks in Central Romania. Life 2021;11:1004. DOI: https://doi.org/10.3390/life11101004
Baldi E, Savastano S, Cortese G, et al. Patient voluntarily delays call to emergency medical system for ST-elevation myocardial infarction during COVID-19 pandemic. Int J Cardiol Heart Vasc 2021;35:100824. DOI: https://doi.org/10.1016/j.ijcha.2021.100824
Otero D, Singam NSV, Barry N, et al. Complication of late presenting STEMI due to avoidance of medical care during COVID-19 pandemic. JACC Case Rep 2020;2(10):1610–1613. doi:10.1016/j.jaccas.2020.05.045. DOI: https://doi.org/10.1016/j.jaccas.2020.05.045
De Luca G, Verdoia M, Cercek M, et al. Impact of COVID-19 pandemic on mechanical reperfusion for patients with STEMI. J Am Coll Cardiol 2020;76:2321-30. DOI: https://doi.org/10.1016/j.jacc.2020.09.546
Tam CF, Siu CD, Tse HF. Challenges in management of ST elevation myocardial infarction during COVID-19 pandemic. Cardiol Plus 2021;6:218-30. DOI: https://doi.org/10.4103/2470-7511.334400
Kamarullah W, Sabrina AP, Rocky MA, Gozali DR. Investigating the implications of COVID-19 outbreak on systems of care and outcomes of STEMI patients: a systematic review and meta-analysis. Indian Heart J 2021;73:404-12. DOI: https://doi.org/10.1016/j.ihj.2021.06.009
Chandrashekhar Y, Alexander T, Mullasari AS, et al. Resource and infrastructure-appropriate management of ST-segment elevation myocardial infarction in low- and middle-income countries. Circulation 2020;141:2004-25. DOI: https://doi.org/10.1161/CIRCULATIONAHA.119.041297
Landon BE, Hatfield LA, Bakx P, et al. Differences in treatment patterns and outcomes of acute myocardial infarction for low- and high-income patients in 6 countries. JAMA 2023;329:1088-97. DOI: https://doi.org/10.1001/jama.2023.1699
Alexander T, Mullasari AS, Joseph G, et al. A System of Care for Patients With ST-Segment Elevation Myocardial Infarction in India: the Tamil Nadu-ST-segment elevation myocardial infarction program. JAMA Cardiol 2017;2:498-505. DOI: https://doi.org/10.1001/jamacardio.2016.5977
Di Domenicantonio R, Cappai G, Sciattella P, et al. The tradeoff between travel time from home to hospital and door to balloon time in determining mortality among STEMI patients undergoing PCI. PLoS One 2016;11:e0158336. DOI: https://doi.org/10.1371/journal.pone.0158336
Minha S, Gilutz H, Cohen M, et al. Transfer distance effect on reperfusion: timeline of ST-elevation patients transferred for primary percutaneous coronary intervention. Cardiovasc Revasc Med 2014;15:369-74. DOI: https://doi.org/10.1016/j.carrev.2014.08.003
French WJ, Granger CB, Henry TD, et al. Emergency interhospital transfer of patients with ST-segment-elevation myocardial infarction: call 9-1-1—the American Heart Association mission: lifeline program. J Am Heart Assoc 2022;11:e026700. DOI: https://doi.org/10.1161/JAHA.122.026700
Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J 2017;38:774-84. DOI: https://doi.org/10.1093/eurheartj/ehw224
Maroko PR, Libby P, Ginks WR, et al. Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. J Clin Invest 1972;51:2710-6. DOI: https://doi.org/10.1172/JCI107090
Ginks WR, Sybers HD, Maroko PR, et al. Coronary artery reperfusion. II. Reduction of myocardial infarct size at 1 week after the coronary occlusion. J Clin Invest 1972;51:2717-23. DOI: https://doi.org/10.1172/JCI107091
Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
Verma S, Fedak PW, Weisel RD, et al. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 2002;105:2332-6. DOI: https://doi.org/10.1161/01.CIR.0000016602.96363.36
De Villiers C, Riley PR. Mouse models of myocardial infarction: comparing permanent ligation and ischaemia-reperfusion. Dis Model Mech 2020;13:dmm046565. DOI: https://doi.org/10.1242/dmm.046565
Schömig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 2000;343:385-91. DOI: https://doi.org/10.1056/NEJM200008103430602
Schömig A, Ndrepepa G, Kastrati A. Late myocardial salvage: time to recognize its reality in the reperfusion therapy of acute myocardial infarction. Eur Heart J 2006;27:1900-7. DOI: https://doi.org/10.1093/eurheartj/ehl174
Schmidt MR, Rasmussen ME, Bøtker HE. Remote ischemic conditioning for patients with STEMI. J Cardiovasc Pharmacol Ther 2017;22:302-9. DOI: https://doi.org/10.1177/1074248417702481
Verdouw PD, van den Doel MA, de Zeeuw S, Duncker DJ. Animal models in the study of myocardial ischaemia and ischaemic syndromes. Cardiovasc Res 1998;39:121-35. DOI: https://doi.org/10.1016/S0008-6363(98)00069-8
Habib GB, Heibig J, Forman SA, et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. Circulation 1991;83:739-46. DOI: https://doi.org/10.1161/01.CIR.83.3.739
Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987;21:737-46. DOI: https://doi.org/10.1093/cvr/21.10.737
Prasad A, Gersh BJ, Mehran R, et al. Effect of ischemia duration and door-to-balloon time on myocardial perfusion in ST-segment elevation myocardial infarction: an analysis from HORIZONS-AMI trial. JACC Cardiovasc Interv 2015;8:1966-74. DOI: https://doi.org/10.1016/j.jcin.2015.08.031
Khan JN, Razvi N, Nazir SA, et al. Prevalence and extent of infarct and microvascular obstruction following different reperfusion therapies in ST-elevation myocardial infarction. J Cardiovasc Magn Reson 2014;16:38. DOI: https://doi.org/10.1186/1532-429X-16-38
Basso C, Thiene G. The pathophysiology of myocardial reperfusion: a pathologist’s perspective. Heart 2006;92:1559-62. DOI: https://doi.org/10.1136/hrt.2005.086959
Weir RA, Murphy CA, Petrie CJ, et al. Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction. Circ Cardiovasc Imaging 2010;3:360-7. DOI: https://doi.org/10.1161/CIRCIMAGING.109.897439
Rios-Navarro C, Marcos-Garces V, Bayes-Genis A, et al. Microvascular obstruction in ST-segment elevation myocardial infarction: looking back to move forward. Focus on CMR. J Clin Med 2019;8:1805. DOI: https://doi.org/10.3390/jcm8111805
Mather AN, Fairbairn TA, Ball SG, et al. Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling. Radiology 2011;261:116-26. DOI: https://doi.org/10.1148/radiol.11110228
Gräni C, Stark AW, Fischer K, et al. Diagnostic performance of cardiac magnetic resonance segmental myocardial strain for detecting microvascular obstruction and late gadolinium enhancement in patients presenting after a ST-elevation myocardial infarction. Front Cardiovasc Med 2022;9:909204. DOI: https://doi.org/10.3389/fcvm.2022.909204
Kumar A, Green JD, Sykes JM, et al. Detection and quantification of myocardial reperfusion hemorrhage using T2*-weighted CMR. JACC Cardiovasc Imaging 2011;4:1274-83. DOI: https://doi.org/10.1016/j.jcmg.2011.08.016
Wen ZJ, Xin H, Wang YC, et al. Emerging roles of circRNAs in the pathological process of myocardial infarction. Mol Ther Nucleic Acids 2021;26:828-48. DOI: https://doi.org/10.1016/j.omtn.2021.10.002
Rodrigues JA, Melleu K, Schmidt MM, et al. Independent predictors of late presentation in patients with ST-segment elevation myocardial infarction. Arq Bras Cardiol 2018;111:587-93. DOI: https://doi.org/10.5935/abc.20180178
McNair PW, Bilsker M, Schooley M, et al. Very late presentation in ST elevation myocardial infarction: predictors and long-term mortality. Int J Cardiol Heart Vasc 2019;22:156-9. DOI: https://doi.org/10.1016/j.ijcha.2019.02.002
Fan X, Maharjan P, Liu P, Bai L. Effect of primary PCI on the recovery of atrioventricular block in inferior STEMI patients with late presentation (>12 hours): insights from a single center 10-year experience. J Investig Med. 2020;68(5):1011-1014. doi:10.1136/jim-2019-001255
Cho KH, Han X, Ahn JH, et al. Long-term outcomes of patients with late presentation of ST-segment elevation myocardial infarction. JACC 2021;77:1859-70. DOI: https://doi.org/10.1016/j.jacc.2021.02.041
Shenoy N, Devasia T. Comparison of outcomes between early and late presentation of ST-elevation myocardial infarction in patients with cardiogenic shock. Int J Cardiovasc Acad 2024;10:53-9. DOI: https://doi.org/10.4274/ijca.2024.41861
Fernandes GC, Costa JR, Almeida RF, et al. Determinants of early and late in-hospital mortality after acute myocardial infarction: a subanalysis of the OBTAIN registry. Can J Cardiol 2023;39:531-7. DOI: https://doi.org/10.1016/j.cjca.2022.10.019
Damluji AA, van Diepen S, Katz JN, et al. Mechanical complications of acute myocardial infarction: a scientific statement from the American Heart Association. Circulation 2021;144:e16-35. DOI: https://doi.org/10.1161/CIR.0000000000000985
Aoun J, Kleiman NS, Goel SS. (2021). Diagnosis and management of late-presentation ST-elevation myocardial infarction and complications. Interv Cardiol Clin 2021;10:369-80. DOI: https://doi.org/10.1016/j.iccl.2021.03.008
Fan X, Maharjan P, Liu P, Bai L. Effect of primary PCI on the recovery of atrioventricular block in inferior STEMI patients with late presentation (>12 hours): insights from a single center 10-year experience. J Investig Med. 2020;68(5):1011-1014. doi:10.1136/jim-2019-001255 DOI: https://doi.org/10.1136/jim-2019-001255
Rittersma SZ, van der Wal AC, Koch KT, et al. Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation 2005;111:1160-5. DOI: https://doi.org/10.1161/01.CIR.0000157141.00778.AC
Yang Y, Li J, Xu W, et al. Thrombus aspirated from patients with ST-elevation myocardial infarction: clinical and angiographic outcomes. J Int Med Res 2016;44:1514-23. DOI: https://doi.org/10.1177/0300060516667373
Nepper-Christensen L, Lønborg J, Høfsten DE, et al. Benefit from reperfusion with primary percutaneous coronary intervention beyond 12 hours of symptom duration in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv 2018;11:e006842. DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.118.006842
Busk M, Kaltoft A, Nielsen SS, et al. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h. Eur Heart J 2009;30:1322-30. DOI: https://doi.org/10.1093/eurheartj/ehp113
APEX AMI Investigators, Armstrong PW, Granger CB, et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA 2007;297:43-51. DOI: https://doi.org/10.1001/jama.297.1.43
Alkhalil M, Choudhury RP. Reperfusion treatment in late presentation acute myocardial infarction. Circulation 2018;11:e007287. DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.118.007287
Mayr A, Bartko P, Reiter C, Toma A. Evolution of myocardial tissue injury: a CMR study over a decade after STEMI. JACC Cardiovasc Imaging 2022;15:1030-42. DOI: https://doi.org/10.1016/j.jcmg.2022.02.010
Limalanathan S, Eritsland J, Andersen GØ, et al. Myocardial salvage is reduced in primary PCI-treated STEMI patients with microvascular obstruction, demonstrated by early and late CMR. PLoS One 2013;8:e71780. DOI: https://doi.org/10.1371/journal.pone.0071780
Bigler MR, Tada Y, Billinger M, et al. Algorithm for real-time analysis of intracoronary electrocardiogram. Front Cardiovasc Med 2022;9:930717. DOI: https://doi.org/10.3389/fcvm.2022.930717
Wong DTL, Bertovic DA, Lee RJ, et al. Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size. Int J Cardiol 2013;165:61-6. DOI: https://doi.org/10.1016/j.ijcard.2011.07.078
Li W, He J, Fan J, et al. Prognostic and diagnostic accuracy of intracoronary electrocardiogram recorded during percutaneous coronary intervention: a meta-analysis. BMJ Open 2022;12:e055871. DOI: https://doi.org/10.1136/bmjopen-2021-055871
Topal DG, Nepper-Christensen L, Lønborg J, et al. Electrocardiogram to predict reperfusion success in late presenters with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Electrocardiol 2020;59:74-80. DOI: https://doi.org/10.1016/j.jelectrocard.2020.01.008
Mahdiui ME, El Mahdiui M, van der Bijl P, et al. Myocardial work, an echocardiographic measure of post myocardial infarct scar on contrast-enhanced cardiac magnetic resonance. Am J Cardiol 2021;151:1-9. DOI: https://doi.org/10.1016/j.amjcard.2021.04.009
Gvinianidze L, Toulemonde M, Hampson R, et al. Ultrafast myocardial contrast echocardiography for the assessment of coronary artery disease: first in-human study. Circ Cardiovasc Imaging 2024;17:e017267. DOI: https://doi.org/10.1161/CIRCIMAGING.124.017267
Hathaway QA, Jamthikar AD, Rajiv N, et al. Cardiac ultrasomics for acute myocardial infarction risk stratification and prediction of all-cause mortality: a feasibility study. Echo Res Pract 2024;11:22. DOI: https://doi.org/10.1186/s44156-024-00057-w
Cong T, Sun Y, Shang Z, et al. Prognostic value of speckle tracking echocardiography in patients with ST-elevation myocardial infarction treated with late percutaneous intervention. Echocardiography 2015;32:1384-91. DOI: https://doi.org/10.1111/echo.12864
Gaibazzi N, Bianconcini M, Marziliano N, et al. Scar detection by pulse-cancellation echocardiography: validation by CMR in patients with recent STEMI. JACC Cardiovasc Imaging 2016;9:1239-51. DOI: https://doi.org/10.1016/j.jcmg.2016.01.021
Schömig A, Mehilli J, Antoniucci D, et al. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA 2005;293:2865-72. DOI: https://doi.org/10.1001/jama.293.23.2865
Ndrepepa G, Kastrati A, Mehilli J, et al. Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms. JAMA 2009;301:487-8. DOI: https://doi.org/10.1001/jama.2009.32
Gierlotka M, Gasior M, Wilczek K, et al. Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms: a prospective national observational study. Am J Cardiol 2011;107:501-8. DOI: https://doi.org/10.1016/j.amjcard.2010.10.008
Gimple S, Menon V. Lack of benefit with percutaneous intervention for late persistent occlusion after myocardial infarction: summary of the occluded artery trial. J Cardiovasc Nurs 2008;23:30-3. DOI: https://doi.org/10.1097/01.JCN.0000305055.58129.35
Dzavík V, Buller CE, Lamas GA, et al. Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial. Circulation 2006;114:2449-57. DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.669432
Xiu WJ, Yang HT, Zheng YY, et al. Delayed PCI 12 hours after the onset of symptoms is associated with improved outcomes for patients with ST-segment elevation myocardial infarction: a real-world study. J Interv Cardiol 2019;2019:2387929. DOI: https://doi.org/10.1155/2019/2387929
Koutsoukis A, Kanakakis I. Challenges and unanswered questions in STEMI management. Hellenic J Cardiol 2019;60:211-5. DOI: https://doi.org/10.1016/j.hjc.2019.01.001
Kastrati A, Coughlan JJ, Ndrepepa G. Primary PCI, late presenting STEMI, and the limits of time. J Am Coll Cardiol 2021;78:1306-8. DOI: https://doi.org/10.1016/j.jacc.2021.08.001
De Luca L, Veneziano FA, Karaboue M. Late presenters with ST-elevation myocardial infarction: a call to action. J Clin Med 2022;11:5169. DOI: https://doi.org/10.3390/jcm11175169
Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur Heart J 2018;39:213-60. DOI: https://doi.org/10.1016/j.rec.2017.11.020
Bi X, Wang B, Tse G, et al. Clinical manifestation of cardiac rupture in patients with ST-segment elevation myocardial infarction: early versus late primary percutaneous coronary intervention. Glob Heart 2022;17:69. DOI: https://doi.org/10.5334/gh.1155
Park H, Kim HK, Jeong MH, et al. Clinical impacts of inhibition of renin-angiotensin system in patients with acute ST-segment elevation myocardial infarction who underwent successful late percutaneous coronary intervention. J Cardiol 2017;69:216-21. DOI: https://doi.org/10.1016/j.jjcc.2016.03.012
How to Cite
“ST-Elevation Myocardial Infarction Late-Presenting Patients: Time for a New Paradigm?”. 2025. Monaldi Archives for Chest Disease, July. https://doi.org/10.4081/monaldi.2025.3372.
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.